Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Calpains
More Information »Calpains are a group of calcium-sensitive cysteine proteases that are ubiquitously expressed in mammals. Structurally, calpains contain two subunits; an 80 kDa catalytic subunit and a 28 kDa regulatory subunit that functions as a chaperone to stabilize the 80 kDa structure.
Calpain Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 2950 | Acetyl-Calpastatin (184-210) (human) |
| Selective calpain inhibitor | |
| 0448 | Calpeptin |
| Calpain and cathepsin L inhibitor | |
| 1146 | MDL 28170 |
| Potent, selective calpain and cathepsin B inhibitor | |
| 3358 | MG 101 |
| Calpain inhibitor; activates p53-dependent apoptosis | |
| 1748 | MG 132 |
| Proteasome and calpain inhibitor. Inhibits NF-κB activation | |
| 1269 | PD 150606 |
| Cell permeable calpain inhibitor | |
Related Categories
Quick Order
Find multiple products by catalog number
Calcium Imbalance and Neuroprotective Targets
Written by E. Besancon et al
'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.
Apoptosis Pathway
Apoptosis is a mechanism of cell death which occurs after sufficient cellular damage. View pathway or download PDF today.
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.